Tumor immune evasion arises through loss of TNF sensitivity

Area of Science:

• Cancer Biology
• Immunology
• Genetics

Background:

• Immunotherapy has transformed cancer treatment, yet resistance mechanisms are not fully understood.
• Tumor immune evasion from cytotoxic lymphocytes (CD8+ T cells and NK cells) is a major challenge in cancer therapy.

Purpose of the Study:

• To identify genetic mechanisms of tumor immune evasion using whole-genome CRISPR screens.
• To understand how tumors resist killing by cytotoxic lymphocytes and evade antitumor immune responses.

Main Methods:

• Conducted whole-genome clustered regularly interspaced short palindromic repeat (CRISPR)-based screens in vitro and in vivo.
• Analyzed the impact of gene deletions in tumor necrosis factor (TNF) signaling, interferon-γ (IFN-γ) signaling, and antigen presentation pathways.
• Investigated the role of the metabolic protein 2-aminoethanethiol dioxygenase (Ado) in immune evasion.

Main Results:

• Deletion of genes in TNF, IFN-γ, and antigen presentation pathways conferred resistance to CD8+ T cell killing and blunted antitumor responses.
• TNF pathway gene deletions were critical for immune evasion from natural killer (NK) cells.
• Ado was identified as a modulator of sensitivity to TNF-mediated killing and essential for tumor control in vivo.
• Tumors acquired resistance to cytokine-mediated effects, demonstrating a dominant immune evasion strategy.

Conclusions:

• Tumor cells primarily evade immune responses by resisting T cell-derived cytokine effects, particularly TNF-mediated killing.
• TNF signaling is crucial for both CD8+ T cell and NK cell-mediated tumor cell killing.
• The study provides a comprehensive view of pathways involved in immune-mediated tumor surveillance.